Usefulness of CT volumetry for primary gastric lesions in predicting pathologic response to neoadjuvant chemotherapy in advanced gastric cancer

被引:50
作者
Lee, Sang Min [1 ]
Kim, Se Hyung [1 ,2 ]
Lee, Jeong Min [1 ,2 ]
Im, Seock-Ah [3 ]
Bang, Yung-Jue [3 ]
Kim, Woo Ho [4 ]
Kim, Min A. [4 ]
Yang, Han-Kwang [5 ]
Lee, Hyuk-Joon [5 ]
Kang, Won Jun [6 ]
Han, Joon Koo [1 ,2 ]
Choi, Byung Ihn [1 ,2 ]
机构
[1] Seoul Natl Univ, Dept Radiol, Coll Med, Seoul 110744, South Korea
[2] Seoul Natl Univ Hosp, Inst Radiat Med, Seoul 110744, South Korea
[3] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea
[4] Seoul Natl Univ Hosp, Dept Pathol, Seoul 110744, South Korea
[5] Seoul Natl Univ Hosp, Dept Surg, Seoul 110744, South Korea
[6] Yonsei Univ, Dept Nucl Med, Coll Med, Seoul 120749, South Korea
来源
ABDOMINAL IMAGING | 2009年 / 34卷 / 04期
关键词
CT; Volumetry; Gastric cancer; Neoadjuvant chemotherapy; Pathologic response; MULTIDETECTOR ROW CT; STATISTICS; EVALUATE;
D O I
10.1007/s00261-008-9420-8
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
To investigate the utility of CT volumetry for primary gastric lesions in the prediction of pathologic response to neoadjuvant chemotherapy in patients with resectable advanced gastric cancer (AGC). Thirty-three consecutive patients with resectable AGC stage a parts per thousand yenT2 and N1), who had been treated with neoadjuvant chemotherapy and radical gastric resection, were prospectively enrolled in this study. There were 30 men and 3 women with a mean age of 53.8 years. Contrast-enhanced CT was obtained after gastric distention with air before and after chemotherapy using a MDCT scanner. Pre- and post-chemotherapy thickness or short diameter and volume of the primary gastric tumor and largest lymph node (LN), were measured using a dedicated 3D software by two radiologists in consensus. PET/CT was also performed and the peak standardized uptake value (SUV) of primary gastric tumor and largest LN before and after chemotherapy was measured. The percentage diameter, volume, and SUV reduction rates for both the primary gastric tumor and the LN, were calculated and correlated with the histopathologic grades of regression using the Spearman correlation test. Differentiation between pathologic responders and nonresponders was assessed using receiver operating characteristic (ROC) analysis. Among the three CT parameters which showed significant correlation with the histopathologic grades of regression, the correlation factor was highest in the percentage volume reduction rate of primary gastric tumor (rho = 0.484, P = 0.004) followed by percentage volume reduction of the index node (rho = 0.397, P = 0.022), and percentage diameter reduction of the index node (rho = 0.359, P = 0.04). However, the percentage thickness decrease rate (P = 0.208) and the percentage SUV reduction rate (P = 0.619) of primary gastric tumor were not significantly correlated with the histopathologic grades of regression. When the optimal cutoff value of the percentage volume reduction rate of primary gastric tumor was determined to be 35.6%, a sensitivity of 100% (16/16) and a specificity of 58.8% (10/17) were achieved. CT volumetry for primary gastric tumor may be the most accurate tool in the prediction of pathologic response following neoadjuvant chemotherapy in patients with resectable AGC.
引用
收藏
页码:430 / 440
页数:11
相关论文
共 27 条
  • [1] [Anonymous], AJCC CANC STAGING MA
  • [2] Adenocarcinomas of esophagogastric junction: Multi-detector row CT to evaluate early response to neoadjuvant chemotherapy
    Beer, AJ
    Wieder, HA
    Lordick, F
    Ott, K
    Fischer, M
    Becker, K
    Stollfuss, J
    Rummeny, EJ
    [J]. RADIOLOGY, 2006, 239 (02) : 472 - 480
  • [3] Gastric cancer: Preoperative local staging with 3D multi-detector row CT - Correlation with surgical and histopathologic results
    Chen, Chiao-Yun
    Hsu, Jui-Sheng
    Wu, Deng-Chyang
    Kang, Wan-Yi
    Hsieh, Jan-Sing
    Jaw, Twei-Shiun
    Wu, Ming-Tsang
    Liu, Gin-Chung
    [J]. RADIOLOGY, 2007, 242 (02) : 472 - 482
  • [4] Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
    Cunningham, David
    Allum, William H.
    Stenning, Sally P.
    Thompson, Jeremy N.
    Van de Velde, Cornelis J. H.
    Nicolson, Marianne
    Scarffe, J. Howard
    Lofts, Fiona J.
    Falk, Stephen J.
    Iveson, Timothy J.
    Smith, David B.
    Langley, Ruth E.
    Verma, Monica
    Weeden, Simon
    Chua, Yu Jo
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (01) : 11 - 20
  • [5] Pathological features of rectal cancer after preoperative radiochemotherapy
    Dworak, O
    Keilholz, L
    Hoffmann, A
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 1997, 12 (01) : 19 - 23
  • [6] Decreasing incidence of both major histologic subtypes of gastric adenocarcinoma -: a population based study in Sweden
    Ekström, AM
    Hansson, LE
    Signorello, LB
    Lindgren, A
    Bergström, R
    Nyrén, O
    [J]. BRITISH JOURNAL OF CANCER, 2000, 83 (03) : 391 - 396
  • [7] Gore RM, 1997, RADIOL CLIN N AM, V35, P295
  • [8] Phase I trial of oral talactoferrin alfa in refractory solid tumors
    Hayes, TG
    Falchook, GF
    Varadhachary, GR
    Smith, DP
    Davis, LD
    Dhingra, HM
    Hayes, BP
    Varadhachary, A
    [J]. INVESTIGATIONAL NEW DRUGS, 2006, 24 (03) : 233 - 240
  • [9] Diagnostic accuracy of multidetector row computed tomography in T- and N staging of gastric cancer with histopathologic correlation
    Hur, Jin
    Park, Mi-Suk
    Lee, Jae Hee
    Lim, Joon Seok
    Yu, Jeong-Sik
    Hong, Yoo Jin
    Kim, Ki Whang
    [J]. JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2006, 30 (03) : 372 - 377
  • [10] Evaluation of the response to treatment of solid tumours - a consensus statement of the International Cancer Imaging Society
    Husband, JE
    Schwartz, LH
    Spencer, J
    Ollivier, L
    King, DM
    Johnson, R
    Reznek, R
    [J]. BRITISH JOURNAL OF CANCER, 2004, 90 (12) : 2256 - 2260